Filter by: patients
Home > Community Treatment Reports and Side Effects > Insulin Glargine Treatment Report
What is Insulin Glargine?

Insulin glargine is a long acting insulin used for the treatment of type 1 diabetes mellitus (insulin dependent, IDDM) and type 2 diabetes mellitus (noninsulin dependent, NIDDM) requiring basal (long-acting) insulin to improve glycemic control.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Diabetes Type 2 227 34 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Diabetes Type 1 86 9 Efficacy_major Efficacy_moderate Efficacy_slight
Other 16 3 Efficacy_major
General health 5 1 Efficacy_slight
Increase effect of another treatment 4 0
Cystic Fibrosis Related Diabetes 3 0

See all 315 patients currently taking Insulin Glargine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 7
Mild
 12
None
 29

Commonly reported side effects, conditions, and hospitalizations associated with Insulin Glargine

Low blood sugar (hypoglycemia) 4
Weight gain 3
Injection site pain 2
Muscle spasm in stomach 1
Muscle fatigue 1
Inability to experience pleasure (anhedonia) 1
See all 16 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Insulin Glargine. See all 155 dosages ►

  100 units weekly 60 intl units daily 100 units daily 300 units daily 1,000 units daily 2,000 units daily 3,000 units daily 4,000 units daily 5,000 units daily 8,000 units daily
  5 Number of Patients: 5 6 Number of Patients: 6 72 Number of Patients: 72 7 Number of Patients: 7 6 Number of Patients: 6 8 Number of Patients: 8 7 Number of Patients: 7 8 Number of Patients: 8 6 Number of Patients: 6 7 Number of Patients: 7  

Reported Stop Reasons

Why Patients Stopped Taking Insulin Glargine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 17   Other: 33%
Doctor's advice 17   Doctor's advice: 33%
Course of treatment ended 13   Course of treatment ended: 25%
Did not seem to work 5   Did not seem to work: 10%
Side effects too severe 3   Side effects too severe: 6%
Change in health plan coverage 3   Change in health plan coverage: 6%
Not indicated 3   Not indicated: 6%
Expense 2   Expense: 4%

See all 48 patients who’ve stopped taking Insulin Glargine

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Insulin Glargine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Insulin Glargine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Insulin Glargine

Always
 32 67%
Usually
 10 21%
Sometimes
 3 6%
Never
 3 6%

Burden

Difficulty being on treatment

Burden of Insulin Glargine

Very
 7 15%
Somewhat
 9 19%
A little
 18 38%
Not at all
 14 29%

Cost

Paid out of pocket

Cost of Insulin Glargine

$200+
 4 12%
$100-199
 7 21%
$50-99
 5 15%
$25-49
 1 3%
< $25
 16 47%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 25, 2012.